Korean Association for the Study of Targeted Therapy
1 clinical trials · Sponsor
◉ Watch Korean Association for the Study of Targeted Therapy
| Record | Firm | Date |
|---|---|---|
| Poziotinib in Stage IV Lung Adenocarcinoma With HER2 Mutation (KASTT001) (NCT02979821) | Korean Association for the Study of Targeted Therapy | 2016-10-01 |
Track Korean Association for the Study of Targeted Therapy automatically
Every clearance here is in the API, with alerts when new ones post.